Dr. Anupamdeep Singh Mehar, MD

Dr. Mehar practices at Ascension Via Christi St. Francis in Wichita, Kansas, part of Ascension Health Alliance.

Dr. Mehar's NPI, 1457840753, was assigned on May 2, 2018. Dr. Mehar holds Kansas license 0445830.

Dr. Mehar's primary practice is Ascension Via Christi St. Francis, at 929 North St Francis Street, Wichita, KS 67214 in Sedgwick County. The practice phone is (316) 268-5000.

Dr. Mehar's primary practice is Ascension Via Christi St. Francis in Wichita, Kansas, part of Ascension Health Alliance. Dr. Mehar is also affiliated with Ascension Via Christi St. Teresa. The medical group on file is Sound Physicians. Dmand AI also links Dr. Mehar to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehar practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mehar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Mehar's licenses on file in 2 states: Kansas and Michigan.

CMS data shows 1,014 Medicare services from Dr. Mehar across 5 procedure codes in 2024, for 277 Medicare patients. Medicare paid $87,813 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Dr. Mehar in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehar's median patient age at 69, with 61% women.

In 2024, Dr. Mehar wrote 302 Medicare Part D claims for 113 patients. 87% of them were for generic drugs. CMS names the drug for 122 of them, across 6 drugs with 11 or more claims each, at $9,098 in total drug cost. In 2023, CMS named 182 claims across 10 drugs.

Dr. Mehar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Mehar from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Biogen, Inc. paid the most, $123.